<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:Consolas;
panose-1:2 11 6 9 2 2 4 3 2 4;}
@font-face
{font-family:Georgia;
panose-1:2 4 5 2 5 4 5 2 3 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
{mso-style-priority:99;
mso-style-link:"Plain Text Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:10.5pt;
font-family:Consolas;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
{mso-style-priority:99;
mso-style-link:"Balloon Text Char";
margin:0cm;
margin-bottom:.0001pt;
font-size:8.0pt;
font-family:"Tahoma","sans-serif";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0cm;
margin-right:0cm;
margin-bottom:0cm;
margin-left:36.0pt;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
span.PlainTextChar
{mso-style-name:"Plain Text Char";
mso-style-priority:99;
mso-style-link:"Plain Text";
font-family:Consolas;}
span.BalloonTextChar
{mso-style-name:"Balloon Text Char";
mso-style-priority:99;
mso-style-link:"Balloon Text";
font-family:"Tahoma","sans-serif";}
span.EmailStyle22
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:windowtext;}
span.EmailStyle23
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle24
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle25
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle26
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle27
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle28
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle29
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle30
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle31
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle32
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle33
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle34
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle35
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle36
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle37
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle38
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle39
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle40
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle41
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle42
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle43
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle44
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle45
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle46
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.apple-converted-space
{mso-style-name:apple-converted-space;}
span.EmailStyle48
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle49
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle50
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle51
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle52
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle53
{mso-style-type:personal;
font-family:"Calibri","sans-serif";
color:#1F497D;}
span.EmailStyle54
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>See below for the e-note announcing the April meeting for PCCN Oakville/Mississauga.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>This will be a great opportunity to hear a very dynamic Canadian PCa radiation oncologist speak about leading edge treatment.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>I urge all to consider attending. <o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Unfortunately, I’ll be out of town.<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span style='color:#1F497D'>Glen <o:p></o:p></span></p><p class=MsoNormal><o:p> </o:p></p><p class=MsoNormal><span lang=EN-US><o:p> </o:p></span></p><p class=MsoNormal><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Picture_x0020_2" o:spid="_x0000_s1026" type="#_x0000_t75" alt=" OAKVILLE/MISSISSAUGA PROSTATE CANCER SUPPORT GROUP
(fellowship, emotional support, information and discussion)
" style='position:absolute;margin-left:151.45pt;margin-top:2.7pt;width:540pt;height:46.15pt;z-index:251660288;visibility:visible;mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:margin'>
<v:imagedata src="cid:image001.wmz@01D2B390.295F4E20" o:title="MISSISSAUGA PROSTATE CANCER SUPPORT GROUP
(fellowship, emotional support, information and discussion)
" />
</v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout;position:absolute;z-index:251660288;margin-left:202px;margin-top:3px;width:720px;height:62px'><img width=720 height=62 src="cid:image003.png@01D2B390.295F4E20" alt=" OAKVILLE/MISSISSAUGA PROSTATE CANCER SUPPORT GROUP
(fellowship, emotional support, information and discussion)
" v:shapes="Picture_x0020_2"></span><![endif]><b><span lang=EN-US style='font-size:12.0pt;font-family:"Georgia","serif";color:#1F497D'> </span></b><b><span lang=EN-US style='font-size:12.0pt;font-family:"Georgia","serif"'> <span style='color:#1F497D'> </span> <span style='color:#1F497D'> </span> </span></b><b><span lang=EN-US><img width=161 height=99 id="Picture_x0020_5" src="cid:image005.jpg@01CF0BC1.574D6F80" alt="cid:image001.jpg@01CDF27E.DB1D8B40"><span style='color:#1F497D'> </span></span></b><b><span lang=EN-US style='font-size:12.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p></o:p></span></b></p><p class=MsoNormal align=center style='text-align:center'><b><i><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><img width=126 height=93 id="Picture_x0020_3" src="cid:image008.jpg@01D28179.FEC931F0" alt="happy-new-year[1]"></span></i></b><span lang=EN-US><a href="http://www.pccn-oakville-mississauga.com/"><span style='font-size:14.0pt;font-family:"Georgia","serif"'>http://www.pccn-oakville-mississauga.com/</span></a></span><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p></o:p></span></b></p><p class=MsoNormal align=center style='text-align:center'><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><b><i><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'> <o:p></o:p></span></i></b></p><p class=MsoNormal><b><span lang=EN-US style='font-size:14.0pt;color:#1F497D'> </span></b><b><span lang=EN-US style='color:#1F497D'> </span></b><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif";color:#1F497D'>WEDNESDAY APRIL 19th</span></b><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif";color:red'> </span></b><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif"'>- 7:00 PM at the WELLSPRING CENTRE,</span></b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif"'> </span><b><span lang=EN-US style='font-size:14.0pt;font-family:"Cambria","serif"'>2545</span></b><b><span lang=EN-US style='font-size:14.0pt;font-family:"Georgia","serif"'> SIXTH LINE in OAKVILLE<o:p></o:p></span></b></p><p class=MsoNormal><span lang=EN-US style='color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:10.0pt;font-family:"Georgia","serif"'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Our next meeting should be one of the highlights of the year. <b>Our guest speaker is Dr Andrew Loblaw</b>. Dr Loblaw is a great supporter of PCCN support groups – he has spoken to PCCN Brampton several times and was the contributor to PCCN Toronto’s “Ask The Doctor” column in its latest newsletter. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Dr Loblaw is a Radiation Oncologist, Clinician Scientist, and Professor in the Department of Radiation Oncology at Sunnybrook Health Sciences Centre. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Dr Loblaw’s clinical practice and research interest focus on improving outcomes for men with prostate cancer and the healthcare system.</span><span lang=EN-US style='font-size:12.0pt;color:black'> <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:12.0pt;color:black'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>He has a particular interest in image-guided radiotherapy, in the design and conduct of clinical trials, and the generation and dissemination of evidence-based guidelines for prostate cancer treatment. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>We have asked Dr Loblaw to speak about “<b>what’s new in prostate cancer treatment at Sunnybrook</b>”.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Because of his special interest in image-guided radiotherapy, we will hear about the latest approaches to radiation treatments for prostate cancer. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>It’s not all about 39 or 40 daily treatments any more:<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Have you hear of SABR? </span><span lang=EN-US><a href="http://toronto.ctvnews.ca/toronto-hospital-tests-new-high-precision-method-of-prostate-cancer-treatment-1.2606790"><span style='font-size:13.0pt;font-family:"Georgia","serif"'>http://toronto.ctvnews.ca/toronto-hospital-tests-new-high-precision-method-of-prostate-cancer-treatment-1.2606790</span></a></span><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Sunnybrook was the first in Canada to use MRI for real-time guidance of radiation treatments. <o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>In brachytherapy, we have members who have had Low Dose Rate (permanent seed implants) and High Dose Rate (short-term internal radiation) at Sunnybrook. Want to know more? Watch this video </span><span lang=EN-US><a href="http://www.prostatecancer.ca/Prostate-Cancer/Treatment/Brachytherapy#.VbEfEKRVhHw"><span style='font-size:13.0pt;font-family:"Georgia","serif"'>http://www.prostatecancer.ca/Prostate-Cancer/Treatment/Brachytherapy#.VbEfEKRVhHw</span></a></span><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Dr Loblaw participated in a just-released update of Cancer Care Ontario’s guideline on brachytherapy for prostate cancer patients.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US><a href="http://www.medscape.com/viewarticle/877952"><span style='font-size:13.0pt;font-family:"Georgia","serif"'>http://www.medscape.com/viewarticle/877952</span></a></span><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>We all need to keep up-to-date with what is new. Even if it’s too late for us, remember about our friends, family and new support group members who will be looking to us to give them guidance in the future.<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Best regards, see you on the 19th<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'>Walter<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-size:13.0pt;font-family:"Georgia","serif";color:#1F497D'><o:p> </o:p></span></p></div></body></html>